Compare TMUS & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TMUS | NVO |
|---|---|---|
| Founded | 1994 | 1923 |
| Country | United States | Denmark |
| Employees | N/A | 69500 |
| Industry | Telecommunications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 209.5B | 212.2B |
| IPO Year | 2004 | N/A |
| Metric | TMUS | NVO |
|---|---|---|
| Price | $181.63 | $49.01 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 20 | 11 |
| Target Price | ★ $256.65 | $51.00 |
| AVG Volume (30 Days) | 5.8M | ★ 10.7M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | 2.06% | ★ 3.19% |
| EPS Growth | ★ 0.62 | N/A |
| EPS | ★ 2.27 | N/A |
| Revenue | ★ $40,604,000,000.00 | N/A |
| Revenue This Year | $9.27 | N/A |
| Revenue Next Year | $4.59 | $3.70 |
| P/E Ratio | $79.41 | ★ $13.60 |
| Revenue Growth | ★ 9.03 | N/A |
| 52 Week Low | $165.66 | $35.12 |
| 52 Week High | $261.50 | $71.80 |
| Indicator | TMUS | NVO |
|---|---|---|
| Relative Strength Index (RSI) | 49.12 | 62.69 |
| Support Level | $174.02 | $42.72 |
| Resistance Level | $202.05 | $50.30 |
| Average True Range (ATR) | 5.74 | 1.16 |
| MACD | 0.65 | 0.29 |
| Stochastic Oscillator | 65.08 | 77.09 |
Deutsche Telekom merged its T-Mobile USA unit with prepaid specialist MetroPCS in 2013, and that firm merged with Sprint in 2020, creating the second-largest wireless carrier in the US. T-Mobile now serves about 86 million postpaid and 26 million prepaid phone customers, equal to around 30% of the US retail wireless market. The firm entered the fixed-wireless broadband market aggressively in 2021 and now serves 8 million residential and business customers with its wireless network. It also serves 1 million fiber broadband customers through joint ventures with fiber network owners. T-Mobile owns a stake in these firms, which provide wholesale access to their networks. In addition, T-Mobile provides wholesale services to wireless resellers.
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.